Neurology

  1. Aimovig (erenumab)
    Aimovig (erenumab)
    by Amgen Inc., Novartis Pharmaceuticals Corporation
    for Migraine
    €698.00
  2. Austedo (deutetrabenazine)
    Austedo (deutetrabenazine)
    by Teva Pharmaceuticals
    for Huntington's Disease, Tardive Dyskenia
    €4,485.00
  3. Calcort (deflazacort)
    Calcort (deflazacort)
    by Merrell Dow/Henning
    for Duchenne Muscular Dystrophy
    €8.51
  4. Edaravone (generic)
    Edaravone (generic)
    by Pfizer Japan Inc.
    for Cerebral Infarction
    €481.00
  5. Fycompa (perampanel)
    Fycompa (perampanel)
    by Eisai Europe Ltd
    for Epilepsy
    €15.80
  6. Ketas (ibudilast)
    Ketas (ibudilast)
    by Kyorin Pharmaceuticals Co
    for Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction
    €70.80
  7. Mavenclad (cladribine)
    Mavenclad (cladribine)
    by Merck Serono Europe Limited
    for Multiple Sclerosis
    €2,587.50
  8. Nuplazid (pimavanserin)
    Nuplazid (pimavanserin)
    by ACADIA Pharmaceuticals Inc
    for Parkinson's Disease
    €5,539.55
  9. Ocrevus (ocrelizumab)
    Ocrevus (ocrelizumab)
    by Roche Registration Limited
    for Multiple Sclerosis
    €8,268.50
View as Grid List

Items 1-9 of 15

Page
per page
Set Descending Direction